Treatment of essential thrombocythaemia by alpha 2a interferon

Lancet. 1988 Oct 22;2(8617):960-1. doi: 10.1016/s0140-6736(88)92625-6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Drug Tolerance
  • Female
  • Humans
  • Interferon Type I / therapeutic use*
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Platelet Count / drug effects
  • Recombinant Proteins
  • Thrombocythemia, Essential / therapy*

Substances

  • Interferon Type I
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins